| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent activity | DNHD1 KIF13B ABCC1 MYO5B HSPA4L SAE1 RNF213 NLRP10 ACIN1 CHD6 ABCG2 ATP6V0D2 ATP2B1 PIF1 | 4.56e-06 | 614 | 106 | 14 | GO:0140657 |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | KIF13B ANK3 CLASP1 IQGAP2 MYO5B CLASP2 JAKMIP3 IQGAP1 FMNL3 LMOD3 ABLIM1 SYNE3 MICAL2 TTLL11 ABCG2 TRAK2 CORO7 | 6.49e-05 | 1099 | 106 | 17 | GO:0008092 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | KIF13B ABCC1 MYO5B RNF213 NLRP10 ACIN1 CHD6 ABCG2 ATP2B1 PIF1 | 1.20e-04 | 441 | 106 | 10 | GO:0016887 |
| GeneOntologyMolecularFunction | actin filament binding | 2.10e-04 | 227 | 106 | 7 | GO:0051015 | |
| GeneOntologyMolecularFunction | actin binding | IQGAP2 MYO5B CLASP2 IQGAP1 FMNL3 LMOD3 ABLIM1 SYNE3 MICAL2 CORO7 | 2.34e-04 | 479 | 106 | 10 | GO:0003779 |
| GeneOntologyMolecularFunction | intracellularly cGMP-activated cation channel activity | 5.76e-04 | 7 | 106 | 2 | GO:0005223 | |
| GeneOntologyMolecularFunction | intracellularly ligand-gated monoatomic ion channel activity | 7.07e-04 | 33 | 106 | 3 | GO:0005217 | |
| GeneOntologyBiologicalProcess | positive regulation of serine-type peptidase activity | 7.53e-05 | 3 | 104 | 2 | GO:1902573 | |
| GeneOntologyBiologicalProcess | mitotic actomyosin contractile ring assembly | 7.53e-05 | 3 | 104 | 2 | GO:1903475 | |
| GeneOntologyBiologicalProcess | mitotic actomyosin contractile ring assembly actin filament organization | 7.53e-05 | 3 | 104 | 2 | GO:1903479 | |
| GeneOntologyBiologicalProcess | assembly of actomyosin apparatus involved in mitotic cytokinesis | 7.53e-05 | 3 | 104 | 2 | GO:1902407 | |
| GeneOntologyBiologicalProcess | positive regulation of serine-type endopeptidase activity | 7.53e-05 | 3 | 104 | 2 | GO:1900005 | |
| GeneOntologyBiologicalProcess | actomyosin contractile ring assembly actin filament organization | 1.50e-04 | 4 | 104 | 2 | GO:2000689 | |
| GeneOntologyBiologicalProcess | negative regulation of cilium-dependent cell motility | 1.50e-04 | 4 | 104 | 2 | GO:1902020 | |
| GeneOntologyBiologicalProcess | negative regulation of cilium movement | 1.50e-04 | 4 | 104 | 2 | GO:0003354 | |
| GeneOntologyBiologicalProcess | negative regulation of flagellated sperm motility | 1.50e-04 | 4 | 104 | 2 | GO:1901318 | |
| GeneOntologyBiologicalProcess | mating plug formation | 1.50e-04 | 4 | 104 | 2 | GO:0042628 | |
| GeneOntologyBiologicalProcess | intracellular transport | KIF13B RGPD2 RANBP2 CDC42BPA ANK3 MYO5B VTA1 VPS54 TFG PIK3R4 EVI5 TOMM70 JUP SYNE3 ITSN2 ATP6V0D2 TRAK2 HERC2 CORO7 | 1.58e-04 | 1496 | 104 | 19 | GO:0046907 |
| GeneOntologyBiologicalProcess | positive regulation of protein localization | ANK3 MYO5B SAE1 CLASP2 PTBP1 IQGAP1 ITPR1 BLK TOMM70 JUP TRIM8 | 1.95e-04 | 591 | 104 | 11 | GO:1903829 |
| GeneOntologyBiologicalProcess | actomyosin structure organization | 2.10e-04 | 239 | 104 | 7 | GO:0031032 | |
| GeneOntologyBiologicalProcess | positive regulation of basement membrane assembly involved in embryonic body morphogenesis | 2.49e-04 | 5 | 104 | 2 | GO:1904261 | |
| GeneOntologyBiologicalProcess | regulation of basement membrane assembly involved in embryonic body morphogenesis | 2.49e-04 | 5 | 104 | 2 | GO:1904259 | |
| GeneOntologyBiologicalProcess | negative regulation of wound healing, spreading of epidermal cells | 2.49e-04 | 5 | 104 | 2 | GO:1903690 | |
| GeneOntologyBiologicalProcess | basement membrane assembly involved in embryonic body morphogenesis | 2.49e-04 | 5 | 104 | 2 | GO:2001197 | |
| GeneOntologyBiologicalProcess | response to magnesium ion | 2.64e-04 | 25 | 104 | 3 | GO:0032026 | |
| GeneOntologyBiologicalProcess | xenobiotic transport across blood-brain barrier | 3.73e-04 | 6 | 104 | 2 | GO:1990962 | |
| GeneOntologyBiologicalProcess | embryonic retina morphogenesis in camera-type eye | 3.73e-04 | 6 | 104 | 2 | GO:0060059 | |
| GeneOntologyBiologicalProcess | fertilization | 3.75e-04 | 263 | 104 | 7 | GO:0009566 | |
| GeneOntologyBiologicalProcess | spermatid differentiation | 4.59e-04 | 272 | 104 | 7 | GO:0048515 | |
| GeneOntologyCellularComponent | cortical microtubule cytoskeleton | 2.43e-04 | 5 | 104 | 2 | GO:0030981 | |
| GeneOntologyCellularComponent | basal cortex | 5.07e-04 | 7 | 104 | 2 | GO:0045180 | |
| GeneOntologyCellularComponent | intracellular cyclic nucleotide activated cation channel complex | 5.07e-04 | 7 | 104 | 2 | GO:0017071 | |
| GeneOntologyCellularComponent | actin cytoskeleton | CDC42BPA ACACA IQGAP2 MYO5B IQGAP1 LMOD3 ABLIM1 JUP SH3PXD2A MICAL2 | 5.98e-04 | 576 | 104 | 10 | GO:0015629 |
| GeneOntologyCellularComponent | basal part of cell | 6.04e-04 | 378 | 104 | 8 | GO:0045178 | |
| GeneOntologyCellularComponent | cytoplasmic periphery of the nuclear pore complex | 6.73e-04 | 8 | 104 | 2 | GO:1990723 | |
| GeneOntologyCellularComponent | cell leading edge | CDC42BPA IQGAP2 CLASP2 ITGB4 IQGAP1 ABLIM1 PLA2G4F ATP2B1 INPP5J | 8.78e-04 | 500 | 104 | 9 | GO:0031252 |
| GeneOntologyCellularComponent | lateral plasma membrane | 1.06e-03 | 90 | 104 | 4 | GO:0016328 | |
| GeneOntologyCellularComponent | nuclear pore cytoplasmic filaments | 1.07e-03 | 10 | 104 | 2 | GO:0044614 | |
| GeneOntologyCellularComponent | hemidesmosome | 1.31e-03 | 11 | 104 | 2 | GO:0030056 | |
| GeneOntologyCellularComponent | cell projection membrane | 1.41e-03 | 431 | 104 | 8 | GO:0031253 | |
| GeneOntologyCellularComponent | cell cortex region | 1.46e-03 | 45 | 104 | 3 | GO:0099738 | |
| Domain | HEAT | 9.76e-07 | 58 | 107 | 6 | IPR000357 | |
| Domain | HEAT | 7.91e-06 | 48 | 107 | 5 | PF02985 | |
| Domain | TPR | 9.36e-06 | 129 | 107 | 7 | SM00028 | |
| Domain | TPR_repeat | 1.14e-05 | 133 | 107 | 7 | IPR019734 | |
| Domain | TPR-contain_dom | 2.50e-05 | 150 | 107 | 7 | IPR013026 | |
| Domain | Semenogelin | 3.25e-05 | 2 | 107 | 2 | PF05474 | |
| Domain | Semenogelin | 3.25e-05 | 2 | 107 | 2 | IPR008836 | |
| Domain | HEAT_REPEAT | 5.06e-05 | 70 | 107 | 5 | PS50077 | |
| Domain | RasGAP_C | 9.72e-05 | 3 | 107 | 2 | IPR000593 | |
| Domain | RasGAP_C | 9.72e-05 | 3 | 107 | 2 | PF03836 | |
| Domain | ARM-type_fold | 1.45e-04 | 339 | 107 | 9 | IPR016024 | |
| Domain | TPR_1 | 1.68e-04 | 90 | 107 | 5 | IPR001440 | |
| Domain | TPR_1 | 1.68e-04 | 90 | 107 | 5 | PF00515 | |
| Domain | - | 1.90e-04 | 207 | 107 | 7 | 1.25.40.10 | |
| Domain | CLZ | 1.94e-04 | 4 | 107 | 2 | PF16526 | |
| Domain | CLASP_N | 1.94e-04 | 4 | 107 | 2 | PF12348 | |
| Domain | CLASP_N_dom | 1.94e-04 | 4 | 107 | 2 | IPR024395 | |
| Domain | CLZ_dom | 1.94e-04 | 4 | 107 | 2 | IPR032406 | |
| Domain | Taxilin | 1.94e-04 | 4 | 107 | 2 | PF09728 | |
| Domain | TPR_8 | 2.40e-04 | 53 | 107 | 4 | PF13181 | |
| Domain | HnRNP-L/PTB | 3.22e-04 | 5 | 107 | 2 | IPR006536 | |
| Domain | TPR_REGION | 3.76e-04 | 165 | 107 | 6 | PS50293 | |
| Domain | TPR | 3.76e-04 | 165 | 107 | 6 | PS50005 | |
| Domain | TPR-like_helical_dom | 3.89e-04 | 233 | 107 | 7 | IPR011990 | |
| Domain | ARM-like | 9.31e-04 | 270 | 107 | 7 | IPR011989 | |
| Domain | - | 1.76e-03 | 222 | 107 | 6 | 1.25.10.10 | |
| Domain | Ran_BP1 | 2.07e-03 | 12 | 107 | 2 | PF00638 | |
| Domain | RANBD1 | 2.07e-03 | 12 | 107 | 2 | PS50196 | |
| Domain | RanBD | 2.43e-03 | 13 | 107 | 2 | SM00160 | |
| Domain | Ran_bind_dom | 2.43e-03 | 13 | 107 | 2 | IPR000156 | |
| Domain | RasGAP | 2.83e-03 | 14 | 107 | 2 | SM00323 | |
| Domain | RasGAP_CS | 2.83e-03 | 14 | 107 | 2 | IPR023152 | |
| Domain | RasGAP | 3.25e-03 | 15 | 107 | 2 | PF00616 | |
| Domain | RAS_GTPASE_ACTIV_1 | 3.25e-03 | 15 | 107 | 2 | PS00509 | |
| Domain | RAS_GTPASE_ACTIV_2 | 3.25e-03 | 15 | 107 | 2 | PS50018 | |
| Domain | P-loop_NTPase | DNHD1 KIF13B ABCC1 TPST1 MYO5B RNF213 IQGAP1 NLRP10 TRANK1 CHD6 ABCG2 PIF1 | 3.36e-03 | 848 | 107 | 12 | IPR027417 |
| Domain | cNMP-bd_CS | 3.70e-03 | 16 | 107 | 2 | IPR018488 | |
| Domain | - | 3.70e-03 | 16 | 107 | 2 | 1.10.506.10 | |
| Domain | HEAT_type_2 | 4.18e-03 | 17 | 107 | 2 | IPR021133 | |
| Domain | RasGAP_dom | 4.69e-03 | 18 | 107 | 2 | IPR001936 | |
| Pubmed | KIF13B RGPD2 RANBP2 IQGAP2 MYO5B HSPA4L PTBP2 PRPF6 HEATR1 PTBP1 CEP128 ERLIN1 IQGAP1 LMOD3 SH3PXD2A ITSN2 ACIN1 UGGT2 CHD6 ATP2B1 NIPBL | 2.65e-09 | 1442 | 107 | 21 | 35575683 | |
| Pubmed | TET2 ANK3 HIPK1 VPS54 JAKMIP3 REV3L IQGAP1 RUFY2 PIK3R4 ABLIM1 NELL2 FBN1 EHMT2 MICAL2 TRIM8 CHD6 HERC2 NIPBL GPRASP2 | 1.32e-08 | 1285 | 107 | 19 | 35914814 | |
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | ABCC1 MYO5B SAE1 HEATR1 TFG CEP128 TOMM70 ABLIM1 FBN1 XPNPEP3 UGGT2 HERC2 ATP2B1 GPRASP2 | 8.52e-08 | 754 | 107 | 14 | 33060197 |
| Pubmed | RANBP2 CDC42BPA ACACA MYO5B HSPA4L SAE1 CLASP2 PRPF6 PTBP1 ERLIN1 IQGAP1 ABLIM1 JUP MICAL2 WDR87 TTLL11 ACIN1 | 2.66e-07 | 1247 | 107 | 17 | 27684187 | |
| Pubmed | RANBP2 CDC42BPA ANK3 HIPK1 HIPK2 ITGB4 ABLIM1 JUP ITSN2 CHD6 HERC2 | 3.29e-07 | 486 | 107 | 11 | 20936779 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | DNHD1 RANBP2 TRAF1 ACACA HSPA4L CLASP2 PRPF6 HEATR1 PTBP1 TFG TSFM IQGAP1 PIK3R4 TOMM70 JUP ACIN1 ATP2B1 NIPBL | 3.47e-07 | 1425 | 107 | 18 | 30948266 |
| Pubmed | ANK3 CLASP1 IQGAP2 MYO5B NAT9 HSPA4L CLASP2 PTBP1 IQGAP1 PIK3R4 TOMM70 ABLIM1 JUP MICAL2 ITSN2 CORO7 ATP2B1 CACNA2D3 | 3.69e-07 | 1431 | 107 | 18 | 37142655 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | RANBP2 MYO5B PRPF6 HEATR1 PTBP1 TFG ERLIN1 IQGAP1 ABLIM1 JUP XPNPEP3 ACIN1 HERC2 ATP2B1 NIPBL | 5.91e-07 | 1024 | 107 | 15 | 24711643 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | RANBP2 ACACA SAE1 VTA1 PRPF6 HEATR1 PTBP1 ERLIN1 IQGAP1 PIK3R4 JUP MICAL2 ACIN1 HERC2 CORO7 ATP2B1 NIPBL | 8.22e-07 | 1353 | 107 | 17 | 29467282 |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | ABCC1 TPST1 HSPA4L PBK RNF213 GCNT1 ITGB4 ERLIN1 ITPR1 JUP NELL2 FBN1 TMTC3 MICAL2 UGGT2 ATP2B1 | 8.39e-07 | 1201 | 107 | 16 | 35696571 |
| Pubmed | KIF13B ANK3 IQGAP2 PTBP2 HIPK2 ARHGEF18 CLASP2 HEATR1 ITGB4 ERLIN1 ITPR1 JUP ACIN1 ATP2B1 D2HGDH | 1.20e-06 | 1084 | 107 | 15 | 11544199 | |
| Pubmed | KIF13B RGPD2 RANBP2 ANK3 CLASP1 IQGAP2 ARHGEF18 CLASP2 JAKMIP3 IQGAP1 ABLIM1 EHMT2 HERC2 NIPBL | 1.58e-06 | 963 | 107 | 14 | 28671696 | |
| Pubmed | 2.11e-06 | 272 | 107 | 8 | 31010829 | ||
| Pubmed | ABCC1 RANBP2 CLASP1 RNF213 CLASP2 PRPF6 HEATR1 PTBP1 ITPR1 PIK3R4 TOMM70 SYNE3 HERC2 CORO7 ATP2B1 | 2.99e-06 | 1168 | 107 | 15 | 19946888 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | CDC42BPA ACACA ANK3 PTBP2 HIPK2 ARHGEF18 RNF213 CLASP2 VPS54 ABLIM1 SH3PXD2A MICAL2 TTLL11 XPNPEP3 CHD6 FBXO21 ATP2B1 | 3.00e-06 | 1489 | 107 | 17 | 28611215 |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 3.21e-06 | 202 | 107 | 7 | 33005030 | |
| Pubmed | 3.21e-06 | 202 | 107 | 7 | 24639526 | ||
| Pubmed | Ankyrin-G induces nucleoporin Nup358 to associate with the axon initial segment of neurons. | 7.92e-06 | 13 | 107 | 3 | 31427429 | |
| Pubmed | ABCC1 RANBP2 IQGAP2 HSPA4L RNF213 PRPF6 HEATR1 PTBP1 IFIT3 ERLIN1 IQGAP1 ITPR1 EVI5 TOMM70 ABLIM1 ATP2B1 | 8.52e-06 | 1440 | 107 | 16 | 30833792 | |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | 9.10e-06 | 332 | 107 | 8 | 32786267 | |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | RANBP2 ACACA CLASP1 IQGAP2 HSPA4L SAE1 CLASP2 PRPF6 HEATR1 IQGAP1 PIK3R4 JUP ACIN1 HERC2 D2HGDH | 9.31e-06 | 1284 | 107 | 15 | 17353931 |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 16914514 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 24998570 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 12213192 | ||
| Pubmed | Human CLASP1 is an outer kinetochore component that regulates spindle microtubule dynamics. | 9.38e-06 | 2 | 107 | 2 | 12837247 | |
| Pubmed | IQGAP1 and IQGAP2 are reciprocally altered in hepatocellular carcinoma. | 9.38e-06 | 2 | 107 | 2 | 20977743 | |
| Pubmed | [Isolation and structure determination of two peptides occurring in human seminal plasma]. | 9.38e-06 | 2 | 107 | 2 | 2757795 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 27681424 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 8665951 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 20231426 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 33311447 | ||
| Pubmed | Ganglioside GM1 mediates decapacitation effects of SVS2 on murine spermatozoa. | 9.38e-06 | 2 | 107 | 2 | 18753612 | |
| Pubmed | Mammalian CLASPs are required for mitotic spindle organization and kinetochore alignment. | 9.38e-06 | 2 | 107 | 2 | 16866869 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 8833737 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 27033456 | ||
| Pubmed | Semen-coagulating protein, SVS2, in mouse seminal plasma controls sperm fertility. | 9.38e-06 | 2 | 107 | 2 | 17123940 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 19701196 | ||
| Pubmed | Development of hepatocellular carcinoma in Iqgap2-deficient mice is IQGAP1 dependent. | 9.38e-06 | 2 | 107 | 2 | 18180285 | |
| Pubmed | Evolution of the hominoid semenogelin genes, the major proteins of ejaculated semen. | 9.38e-06 | 2 | 107 | 2 | 14629036 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 12200457 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 19089943 | ||
| Pubmed | Quantification of seminal plasma motility inhibitor/semenogelin in human seminal plasma. | 9.38e-06 | 2 | 107 | 2 | 14581514 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 1517240 | ||
| Pubmed | Mast, a conserved microtubule-associated protein required for bipolar mitotic spindle organization. | 9.38e-06 | 2 | 107 | 2 | 10899121 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 28411177 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 25395676 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 37913973 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 8654389 | ||
| Pubmed | Seminal vesicle protein SVS2 is required for sperm survival in the uterus. | 9.38e-06 | 2 | 107 | 2 | 24591616 | |
| Pubmed | Human Semenogelin 1 Promotes Sperm Survival in the Mouse Female Reproductive Tract. | 9.38e-06 | 2 | 107 | 2 | 32486486 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 21768390 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 18256692 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 17606642 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 19672972 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 22177559 | ||
| Pubmed | Functional preservation of duplicated pair for RSVS III gene in the REST locus of rat 3q42. | 9.38e-06 | 2 | 107 | 2 | 15582586 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 8631362 | ||
| Pubmed | Expression of semenogelins I and II and its prognostic significance in human prostate cancer. | 9.38e-06 | 2 | 107 | 2 | 21557275 | |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | KIF13B RANBP2 ACACA IQGAP2 SAE1 VTA1 PRPF6 HEATR1 IQGAP1 EHMT2 NIPBL | 1.15e-05 | 704 | 107 | 11 | 29955894 |
| Pubmed | RUFY1 binds Arl8b and mediates endosome-to-TGN CI-M6PR retrieval for cargo sorting to lysosomes. | 1.18e-05 | 344 | 107 | 8 | 36282215 | |
| Pubmed | EHMT2 directs DNA methylation for efficient gene silencing in mouse embryos. | 1.25e-05 | 15 | 107 | 3 | 26576615 | |
| Pubmed | TET2 ABCC1 RANBP2 VTA1 PRPF6 HEATR1 PTBP1 IQGAP1 TOMM70 JUP ACIN1 | 1.26e-05 | 711 | 107 | 11 | 33022573 | |
| Pubmed | 1.65e-05 | 102 | 107 | 5 | 9734811 | ||
| Pubmed | ABCC1 CLASP1 ARHGEF18 RNF213 CLASP2 TFG ABLIM1 TMTC3 UGGT2 CHD6 CORO7 | 1.68e-05 | 733 | 107 | 11 | 34672954 | |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | 1.68e-05 | 475 | 107 | 9 | 31040226 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | SEMG2 RANBP2 ACACA CLASP1 RNF213 PRPF6 TFG ERLIN1 TSFM IQGAP1 TOMM70 ABLIM1 JUP ACIN1 CZIB | 1.94e-05 | 1367 | 107 | 15 | 32687490 |
| Pubmed | Transcription factor Foxp3 and its protein partners form a complex regulatory network. | 1.98e-05 | 370 | 107 | 8 | 22922362 | |
| Pubmed | 2.23e-05 | 18 | 107 | 3 | 33323119 | ||
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | 2.40e-05 | 497 | 107 | 9 | 36774506 | |
| Pubmed | 2.65e-05 | 19 | 107 | 3 | 23118302 | ||
| Pubmed | MRG15 is required for pre-mRNA splicing and spermatogenesis. | 2.81e-05 | 3 | 107 | 2 | 27573846 | |
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 19567674 | ||
| Pubmed | Friend or foe: ABCG2, ABCC1 and ABCB1 expression in triple-negative breast cancer. | 2.81e-05 | 3 | 107 | 2 | 33420675 | |
| Pubmed | CLASP2 Links Reelin to the Cytoskeleton during Neocortical Development. | 2.81e-05 | 3 | 107 | 2 | 28285824 | |
| Pubmed | Asymmetric CLASP-dependent nucleation of noncentrosomal microtubules at the trans-Golgi network. | 2.81e-05 | 3 | 107 | 2 | 17543864 | |
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 10411640 | ||
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 26407213 | ||
| Pubmed | Imaging of activity of multidrug resistance-associated protein 1 in the lungs. | 2.81e-05 | 3 | 107 | 2 | 23596979 | |
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 24382439 | ||
| Pubmed | CLASPs attach microtubule plus ends to the cell cortex through a complex with LL5beta. | 2.81e-05 | 3 | 107 | 2 | 16824950 | |
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 30334318 | ||
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 11027412 | ||
| Pubmed | Expression of human nPTB is limited by extreme suboptimal codon content. | 2.81e-05 | 3 | 107 | 2 | 18335065 | |
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 25722290 | ||
| Pubmed | ABC transporters B1, C1 and G2 differentially regulate neuroregeneration in mice. | 2.81e-05 | 3 | 107 | 2 | 22545122 | |
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 29342177 | ||
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 22182917 | ||
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 22493426 | ||
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 15928712 | ||
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 16278376 | ||
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 19067785 | ||
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 12667457 | ||
| Pubmed | Involvement of IQGAP family proteins in the regulation of mammalian cell cytokinesis. | 2.81e-05 | 3 | 107 | 2 | 25229330 | |
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 9523691 | ||
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 19622290 | ||
| Pubmed | Expression and promoter methylation analysis of ATP-binding cassette genes in pancreatic cancer. | 2.81e-05 | 3 | 107 | 2 | 21956451 | |
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 16960658 | ||
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 27689338 | ||
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 33784440 | ||
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 27791185 | ||
| Interaction | ECH1 interactions | 8.26e-06 | 253 | 107 | 9 | int:ECH1 | |
| Cytoband | 3q12.2 | 1.92e-04 | 9 | 107 | 2 | 3q12.2 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 4.23e-06 | 115 | 67 | 6 | 769 | |
| GeneFamily | Cyclic nucleotide gated channels | 5.97e-04 | 10 | 67 | 2 | 250 | |
| Coexpression | SESTO_RESPONSE_TO_UV_C5 | 1.24e-06 | 46 | 107 | 5 | M1470 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | ABCC1 TPST1 RANBP2 CDC42BPA CLASP1 CLASP2 GCNT1 REV3L ITPR1 PIK3R4 EVI5 MICAL2 ITSN2 ATP2B1 NIPBL | 2.09e-06 | 856 | 107 | 15 | M4500 |
| Coexpression | GSE40274_FOXP3_VS_FOXP3_AND_PBX1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN | 1.80e-05 | 199 | 107 | 7 | M9184 | |
| Coexpression | GSE40274_FOXP3_VS_FOXP3_AND_GATA1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN | 1.80e-05 | 199 | 107 | 7 | M9180 | |
| Coexpression | GSE17721_LPS_VS_CPG_16H_BMDC_DN | 1.86e-05 | 200 | 107 | 7 | M4009 | |
| Coexpression | FORTSCHEGGER_PHF8_TARGETS_DN | TRAF1 MYO5B HIPK1 CLASP2 ITGB4 IFIT3 ERLIN1 FBN1 MICAL2 TRIM8 ABCG2 FBXO21 CDCA7L | 1.87e-05 | 783 | 107 | 13 | M2488 |
| Coexpression | HOFT_CD4_POSITIVE_ALPHA_BETA_MEMORY_T_CELL_BCG_VACCINE_AGE_18_45YO_56D_TOP_100_DEG_AFTER_IN_VITRO_RE_STIMULATION_DN | 4.09e-05 | 47 | 107 | 4 | M40911 | |
| Coexpression | LUI_THYROID_CANCER_CLUSTER_1 | 6.11e-05 | 52 | 107 | 4 | M2135 | |
| Coexpression | LAKE_ADULT_KIDNEY_C11_THIN_ASCENDING_LIMB | 6.94e-05 | 169 | 107 | 6 | M39230 | |
| Coexpression | GSE1925_CTRL_VS_IFNG_PRIMED_MACROPHAGE_3H_IFNG_STIM_UP | 8.15e-05 | 174 | 107 | 6 | M6296 | |
| Coexpression | GSE27896_HDAC6_KO_VS_WT_TREG_UP | 8.68e-05 | 176 | 107 | 6 | M8248 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 2.16e-08 | 192 | 107 | 8 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 2.85e-08 | 199 | 107 | 8 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8|bone_marrow / Manually curated celltypes from each tissue | 1.03e-07 | 156 | 107 | 7 | 1545169694f686d28648a68b552c2ae606599d66 | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 5.17e-07 | 198 | 107 | 7 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 5.35e-07 | 199 | 107 | 7 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.53e-07 | 200 | 107 | 7 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.39e-06 | 159 | 107 | 6 | 323cb4a2416d2e6bff0a3f225d2edeae9ab7dc76 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c06-NR4A2|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.66e-06 | 162 | 107 | 6 | 80317c4253bf8e897782e562f29835f181c65b98 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Hematopoietic-B_cells-STAT1+_Naive_B|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.28e-06 | 168 | 107 | 6 | ba127d97697202a8558a0d50bcdafa30b0509de1 | |
| ToppCell | LPS-IL1RA-Hematopoietic_Meg-Ery-Erythroid-Erythroid|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.15e-06 | 175 | 107 | 6 | e4c9b3c6bde390a3892b112b673f93e118220eb9 | |
| ToppCell | LPS-IL1RA-Hematopoietic_Meg-Ery-Erythroid|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.15e-06 | 175 | 107 | 6 | 4d36da7399c62c170cb603957b35a35efb2c3fbe | |
| ToppCell | LPS-IL1RA-Hematopoietic_Meg-Ery|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.15e-06 | 175 | 107 | 6 | 2c39c1b112e873403ad2add8595cc256bf0b97a6 | |
| ToppCell | LPS_only-Lymphocytic_B-B_cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.43e-06 | 177 | 107 | 6 | c82332c5f656aa26513e4f7525d5d4d733019725 | |
| ToppCell | LPS_only-Lymphocytic_B|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.43e-06 | 177 | 107 | 6 | 5ed65e08d773d157840317c72e0d43c261d438d4 | |
| ToppCell | LPS_only-Lymphocytic_B-B_cells-B-cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.43e-06 | 177 | 107 | 6 | 8a955a7ab84c434f9ad4b467246b8be3cb479406 | |
| ToppCell | LPS-IL1RA+antiTNF-Hematopoietic_Meg-Ery|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.72e-06 | 179 | 107 | 6 | 7329b45376a9e9a4fe34d4aa0b33af6dda0a8e3b | |
| ToppCell | LPS-IL1RA+antiTNF-Hematopoietic_Meg-Ery-Erythroid|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.72e-06 | 179 | 107 | 6 | 6e4740f99f66d3e9348fa5057cf1030454819aa8 | |
| ToppCell | LPS-IL1RA+antiTNF-Hematopoietic_Meg-Ery-Erythroid-Erythroid|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.72e-06 | 179 | 107 | 6 | ee60ac43fb62c09967a26bbcf9306ac5ea2bdc1e | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 6.26e-06 | 188 | 107 | 6 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.85e-06 | 191 | 107 | 6 | 1ecd9849d14d5ebf3daf610e83fb50820cafd3ed | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.49e-06 | 194 | 107 | 6 | a44be2f021cfdd0fcdc698c3f04d66db7a1aa6c2 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 8.66e-06 | 199 | 107 | 6 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Meis2-Meis2_Adamts19|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.32e-05 | 69 | 107 | 4 | 130b1a56afe6aee01cde56cb983cbc2c41861bb4 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Meis2|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.32e-05 | 69 | 107 | 4 | 6568fcefcc0dca211f2acf6e4066f795489e758d | |
| ToppCell | PBMC-Control-cDC_1|Control / Compartment, Disease Groups and Clusters | 3.76e-05 | 156 | 107 | 5 | 9b6c5bcac516a62bcc1f5be32ffa8c92735ef0bc | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.11e-05 | 159 | 107 | 5 | 74655c22e9fdd88e3052b9dfb954c8fb678bd2d8 | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 4.50e-05 | 162 | 107 | 5 | b4535bcb3f469bc139e73f1122f4070013e5a1de | |
| ToppCell | normal-na-Lymphocytic_B-B_cell-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 4.50e-05 | 162 | 107 | 5 | ae292318d339305932457bb0e91430594f7a3dfa | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.63e-05 | 163 | 107 | 5 | 6bed27d2f67a430a847da5eb47878d14b4949c45 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.91e-05 | 165 | 107 | 5 | 22293c6b55f44636440cd737efb786ff5de3373d | |
| ToppCell | facs-Kidney-nan-3m-Lymphocytic-B_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.05e-05 | 166 | 107 | 5 | 6a948aefd283a2572da37b59dbc142b6e686b024 | |
| ToppCell | facs-Kidney-nan-3m-Lymphocytic-B_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.05e-05 | 166 | 107 | 5 | 8d0c4eb90a2c006f96ae61d3d94c96fb64bc0c4d | |
| ToppCell | LPS-IL1RA+antiTNF-Lymphocytic_B-B_cells-B-cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.35e-05 | 168 | 107 | 5 | eeb381b62c7ba263af96de1194ed59e57b6ca3ae | |
| ToppCell | LPS-IL1RA+antiTNF-Lymphocytic_B-B_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.35e-05 | 168 | 107 | 5 | 063d0368d656962b335154c230bdcd9236e7c9ad | |
| ToppCell | LPS-IL1RA+antiTNF-Lymphocytic_B|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.35e-05 | 168 | 107 | 5 | a7c4251d8a83bc30196a444028a35c17c24dc291 | |
| ToppCell | LPS-IL1RA-Lymphocytic_B-B_cells-B-cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.65e-05 | 170 | 107 | 5 | 92e0873f618b2fa60c4d555b10f234d5cbcf3325 | |
| ToppCell | LPS-IL1RA-Lymphocytic_B-B_cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.65e-05 | 170 | 107 | 5 | c181991f933b779f99afc3782f292306f209e2ac | |
| ToppCell | LPS-IL1RA-Lymphocytic_B|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.65e-05 | 170 | 107 | 5 | 56284fbfd1e53f67c8c0b7fba64505a4002adba2 | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.81e-05 | 171 | 107 | 5 | 159ce6d5513008532dd7785b915b3fe7440cc4b2 | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_B-GC_B_(I)|bone_marrow / Manually curated celltypes from each tissue | 6.14e-05 | 173 | 107 | 5 | 67f0f0bf88eab69987b71d96b864ed2b14975adb | |
| ToppCell | droplet-Fat-Scat-21m-Endothelial-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.14e-05 | 173 | 107 | 5 | f13124b4cf2ac1dc2895f90f5487d6ac681b0ba4 | |
| ToppCell | LPS-antiTNF-Lymphocytic_B|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.31e-05 | 174 | 107 | 5 | cc493654ea3517bc6a145c7f787f304929636f86 | |
| ToppCell | LPS-antiTNF-Lymphocytic_B-B_cells-B-cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.31e-05 | 174 | 107 | 5 | 9eb3504f9340517ef5d056503044fbdb9ffeb714 | |
| ToppCell | LPS-antiTNF-Lymphocytic_B-B_cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.31e-05 | 174 | 107 | 5 | b4c2d1c029fcd0d4926aa79a5b789c713919dcf3 | |
| ToppCell | facs-Trachea-24m-Mesenchymal-fibroblast-fibroblast_of_trachea-|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.49e-05 | 175 | 107 | 5 | bb898796662b97f7459b7dda7cecf6a9bde8b055 | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_naive-B_naive-1|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.66e-05 | 176 | 107 | 5 | ad05dd934f4ac2e656b3455de091f4c8772de6c8 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.66e-05 | 176 | 107 | 5 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-B_cell-B_naive-B_activate-7|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.66e-05 | 176 | 107 | 5 | dde46f06f6fc3f7ba83be91a0ee6231790955e3e | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.84e-05 | 177 | 107 | 5 | d3e6c768b88b7906f3c7fdd00ba20842212c14b1 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.84e-05 | 177 | 107 | 5 | f8f101c772c043636bedd6b2ec81409b1d2599bf | |
| ToppCell | COVID-19_Mild-Lymphoid_T/NK-NK_activated|COVID-19_Mild / Disease group, lineage and cell class | 6.84e-05 | 177 | 107 | 5 | 6978a22fef40c8b455342373abe7593f5ede0fa4 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.84e-05 | 177 | 107 | 5 | 936ab2b180a052387124f68d0c7f41c0b164e748 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.84e-05 | 177 | 107 | 5 | d5aeda113afaa2425874394610344570c9078478 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.03e-05 | 178 | 107 | 5 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | LPS-antiTNF-Hematopoietic_Meg-Ery-Erythroid|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.03e-05 | 178 | 107 | 5 | eafacc8cd3e986d6ca309e05b6e241331a584fa5 | |
| ToppCell | LPS-antiTNF-Hematopoietic_Meg-Ery|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.03e-05 | 178 | 107 | 5 | 6a5c31e976852edc7d9e899da8e2a1bf23d36759 | |
| ToppCell | LPS-antiTNF-Hematopoietic_Meg-Ery-Erythroid-Erythroid|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.03e-05 | 178 | 107 | 5 | 370749834a11d981e9ede26d5f63f0ecb551c015 | |
| ToppCell | droplet-Lung-30m-Hematologic-lymphocytic-B_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.61e-05 | 181 | 107 | 5 | 477c572c5c1efceee49732cc9e8b1dad68a7e6e5 | |
| ToppCell | droplet-Lung-30m-Hematologic-lymphocytic-B_cell-B_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.61e-05 | 181 | 107 | 5 | 909280b44085d8e96fcd3cbcba6bff94badd41e8 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue | 7.61e-05 | 181 | 107 | 5 | f2315414e714ac86211546a935660c4be6e85f1b | |
| ToppCell | droplet-Lung-LUNG-30m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.61e-05 | 181 | 107 | 5 | ce0e39114bf3bcbcce0fd4c0d70bedadd0853e1d | |
| ToppCell | normal-na-Lymphocytic_B-B_mem-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 7.81e-05 | 182 | 107 | 5 | ee36ea6cb9a5a08aeb83f2b7a249255f0b1a9870 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.81e-05 | 182 | 107 | 5 | 1aea96ee211f7b9caef7fd385233f51be6021a73 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 7.81e-05 | 182 | 107 | 5 | b427e43ee523a3ea9eca3207f3d82042f10f022a | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.81e-05 | 182 | 107 | 5 | c0f63cfc67d61c0877b7acb2946dfb35aae8a8f5 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.81e-05 | 182 | 107 | 5 | 4cb182ef39be2044a6ad7266f332d4177591e550 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c11-MKI67-FOS|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.01e-05 | 183 | 107 | 5 | ba7753e9fe2a6a87c5264f299ac97da2ddbda178 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.01e-05 | 183 | 107 | 5 | 12e876d6205af8aad74265c668b5e95b9e7487f3 | |
| ToppCell | COVID-19_Mild-Lymphoid_T/NK-CD4+_T_activated|COVID-19_Mild / Disease group, lineage and cell class | 8.01e-05 | 183 | 107 | 5 | 7717fce227b4e02ed41baad8ae7dd2e22bd7c13e | |
| ToppCell | (4)_B_cells-(4)_B_mantle|(4)_B_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 8.01e-05 | 183 | 107 | 5 | 21b7fb6482eb1d5d31a4029e47e0992e8ddc8e2c | |
| ToppCell | COVID-19_Mild-NK_activated|COVID-19_Mild / Disease condition and Cell class | 8.01e-05 | 183 | 107 | 5 | 22bd05135906d0ecc4ba8c2e0a666093d1bf3b8f | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-Treg_cell_4|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 8.01e-05 | 183 | 107 | 5 | 3cbe0175d05fd39bc430de1ef471ff2c5b56460e | |
| ToppCell | Immune_cells-large_pre-B.|World / Lineage and Cell class | 8.01e-05 | 183 | 107 | 5 | 81b5ed6ed661d2d6a9b807fefd2f0d59bd4ea77e | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.22e-05 | 184 | 107 | 5 | bd786db4dc4edae6d5cfc0b69901983dea19f729 | |
| ToppCell | PBMC-Severe-Hematopoietic-RBC|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.43e-05 | 185 | 107 | 5 | d685a5a2e525db2eba449cfa1e5cd54eb36162a8 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_B-B_cell-B_c03-CD27-AIM2|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.43e-05 | 185 | 107 | 5 | 3563dd39ec58d3273f95f5bb36b9ccdc0aafb63a | |
| ToppCell | PBMC-Severe-Hematopoietic-RBC|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.43e-05 | 185 | 107 | 5 | 5d8d6fd7800f76ee3aa5cef95241d8e6d7e8db04 | |
| ToppCell | PBMC-Severe-Hematopoietic-RBC-RBC|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 8.43e-05 | 185 | 107 | 5 | 100b5afdf3c6ab07ffc493f7883f5a7b31c59184 | |
| ToppCell | COVID-19_Severe-Hematopoietic_R|COVID-19_Severe / Disease group, lineage and cell class | 8.43e-05 | 185 | 107 | 5 | 30f064ab7c3890e6f419a845276b145112e78f52 | |
| ToppCell | PBMC-Severe-Hematopoietic-RBC-RBC|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.43e-05 | 185 | 107 | 5 | f3b1907c3b6f930bc161f46efce5e143babab507 | |
| ToppCell | PBMC-Severe-Hematopoietic-RBC-RBC-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 8.43e-05 | 185 | 107 | 5 | 44ce50cb99df8ffc50eba311adcf688477618659 | |
| ToppCell | PBMC-Severe-Hematopoietic-RBC-RBC-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.43e-05 | 185 | 107 | 5 | 17542ccd52a821c9e99b1a7469e80502e764b3fd | |
| ToppCell | Control-Lymphoid-T_Regulatory|Lymphoid / Disease state, Lineage and Cell class | 8.43e-05 | 185 | 107 | 5 | e481cacda0b6b25f5f0062b962df9a442053ac30 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.43e-05 | 185 | 107 | 5 | e0172e0ab0f1d7151a3c3c63bb7c84d6bda92035 | |
| ToppCell | COVID-19_Severe-Hematopoietic_R-RBC|COVID-19_Severe / Disease group, lineage and cell class | 8.43e-05 | 185 | 107 | 5 | 3ed6090b822c6d1d400a421236cddc7511743932 | |
| ToppCell | LPS_only-Hematopoietic_Meg-Ery-Erythroid-Erythroid|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.65e-05 | 186 | 107 | 5 | e5014443e9d6e25943308483e20d48b776ae5373 | |
| ToppCell | LPS_only-Hematopoietic_Meg-Ery-Erythroid|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.65e-05 | 186 | 107 | 5 | affc246a1091e44dc85a5e237c778a7541d5a2b4 | |
| ToppCell | LPS_only-Hematopoietic_Meg-Ery|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.65e-05 | 186 | 107 | 5 | 40d1e15402fdfb3b5ae850a2070cd4b68fda3159 | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.65e-05 | 186 | 107 | 5 | 5302399825f213d105ac70b91366a4513b732838 | |
| ToppCell | Control-Lymphoid-B|Lymphoid / Disease state, Lineage and Cell class | 8.87e-05 | 187 | 107 | 5 | 4e64be635f445276e71f2937f33f041c3a4204ab | |
| ToppCell | pdx-Tumor_cells-T5|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 8.87e-05 | 187 | 107 | 5 | 7e376831a11ee72ed87abcdac631ca46ae29c250 | |
| ToppCell | IPF-Lymphoid-B|Lymphoid / Disease state, Lineage and Cell class | 8.87e-05 | 187 | 107 | 5 | af1327559f7e01bec070881cae52834917c3da65 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-B_cell-B_cell|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.09e-05 | 188 | 107 | 5 | 99fdd305f75ed38dd507e7a17ffe27c26b86e454 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.09e-05 | 188 | 107 | 5 | bc089cd73d283ed7d2ecbb3936673b4edc89f666 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.09e-05 | 188 | 107 | 5 | eec3d353e51358db4c7621265ee0fdd4298e5b0e | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-B_cell|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.09e-05 | 188 | 107 | 5 | 5a0519b189e96001d95f9d24363448e8602b8d4d | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-B_cell-B_cell-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.09e-05 | 188 | 107 | 5 | e8b7c1c2eb2e390ad79b358236468b0f15ea58a5 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T5|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 9.09e-05 | 188 | 107 | 5 | b070a0667f1ee9b825b267b6c389b7c42fc436f9 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.32e-05 | 189 | 107 | 5 | b13f315f617840eb5143a4e8a33a657c20365c21 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.32e-05 | 189 | 107 | 5 | a75226616340045b581d08429d2e123e041dee55 | |
| Drug | Hycanthone [3105-97-3]; Down 200; 11.2uM; HL60; HG-U133A | 2.90e-06 | 187 | 107 | 8 | 1614_DN | |
| Drug | Catechin-(+,-) hydrate [7295-85-4]; Up 200; 13.8uM; MCF7; HT_HG-U133A | 4.27e-06 | 197 | 107 | 8 | 3351_UP | |
| Disease | retinal vasculature measurement | 5.31e-04 | 517 | 105 | 8 | EFO_0010554 | |
| Disease | cerebral cavernous malformation (implicated_via_orthology) | 6.76e-04 | 11 | 105 | 2 | DOID:0060669 (implicated_via_orthology) | |
| Disease | atopic asthma | 7.42e-04 | 199 | 105 | 5 | EFO_0010638 | |
| Disease | paraxanthine measurement | 8.09e-04 | 12 | 105 | 2 | EFO_0021178 | |
| Disease | metabolite measurement | 8.92e-04 | 560 | 105 | 8 | EFO_0004725 | |
| Disease | bipolar disorder | 1.08e-03 | 577 | 105 | 8 | MONDO_0004985 | |
| Disease | N-acetylmethionine measurement | 1.28e-03 | 15 | 105 | 2 | EFO_0021427 | |
| Disease | Prostatic Neoplasms | 1.63e-03 | 616 | 105 | 8 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 1.63e-03 | 616 | 105 | 8 | C0376358 | |
| Disease | glutarylcarnitine (C5-DC) measurement | 1.65e-03 | 17 | 105 | 2 | EFO_0800030 | |
| Disease | PR interval | 1.99e-03 | 495 | 105 | 7 | EFO_0004462 | |
| Disease | HbA1c measurement | 2.87e-03 | 675 | 105 | 8 | EFO_0004541 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MVGKLKQNLLLACLV | 1 | O60507 | |
| SALVKRLKGALMLEN | 96 | Q9UKV3 | |
| DLKQQLLLNKLMGKD | 1266 | Q6ZSZ5 | |
| GLMSLQLQEALKKQE | 246 | Q6ZU80 | |
| QQAFDIMKEAIGKLL | 321 | A4D0V7 | |
| QLMKLNSGLGQLILK | 606 | O14639 | |
| MALLKANKDLISAGL | 1 | Q9NZD4 | |
| KQALQKDLNLMAPGL | 151 | O75477 | |
| ANAVLLLLKRMSKQG | 221 | Q9UNQ0 | |
| KKNLLVTMLIDQLCG | 1036 | Q13085 | |
| LSVKQGELQKVILML | 656 | Q96KQ7 | |
| LLKGLNVLDLGLNME | 3741 | Q96M86 | |
| LKQRNTLKDGIIMIQ | 151 | P40259 | |
| LTKLAVQIGKAGLLM | 366 | P20020 | |
| NIVLKLLELGANKML | 196 | Q8WWH4 | |
| NLMDIKIGLLVKNKI | 911 | P46940 | |
| IKLIKGEAGQNLLEM | 331 | P49792 | |
| IAMKLIKLKLQGQQL | 81 | Q9NZM3 | |
| KAIGLQMALDLLANK | 686 | Q96PH1 | |
| VKKVLQRMVGNLLSL | 381 | O94952 | |
| QQVATALMKLKSLGL | 306 | Q9H2X6 | |
| GLVQKIMELQDILAK | 236 | Q99435 | |
| ALILNDINPLGKKRM | 2076 | Q14643 | |
| KEQKKLIAMLENGLG | 411 | Q0VAK6 | |
| KGLKVMNLLELVDQL | 76 | Q86W26 | |
| LQQVATALMKLKSLG | 296 | Q86Z02 | |
| IVLLLSKNAGLMQEA | 1141 | O95714 | |
| LDINGKALALMIKAV | 141 | P0CG22 | |
| QKKEELLNAMVAKLG | 891 | P57737 | |
| LALAIGKLGENMILK | 186 | P43897 | |
| MKNKNNVTEFILLGL | 31 | Q8NGL6 | |
| AIMGLKELRQQVKDL | 521 | O60447 | |
| FANVSQGILLLLMLK | 2536 | Q6KC79 | |
| QGILLLLMLKQHLKN | 2541 | Q6KC79 | |
| LMKKLDILGDNANLT | 656 | Q5VZ66 | |
| IKENKAMLAQLLAEL | 221 | Q96GN5 | |
| ADKMLPLLGAVLLQK | 11 | Q68DD2 | |
| LDNLKKMGQNLARVL | 146 | P16144 | |
| LADGLQKMVPLLNKN | 266 | P14923 | |
| KLQCLLLGKNSLMNL | 726 | Q6P9F7 | |
| LKSLFEILILMGKQN | 166 | O43422 | |
| LILLVKMLNSLLKGQ | 366 | Q06495 | |
| EIDGLQLVKKLAKNM | 81 | Q8IZS8 | |
| QAMIQAAGKLVLIDK | 776 | Q8TD26 | |
| GELGDNLKMKIQVLL | 2856 | P35555 | |
| QKLKQMLEIILALGN | 761 | Q8IVF7 | |
| DLQMLKGEKLQVLKG | 76 | P51451 | |
| VLLGLKLQKMNKEAE | 211 | O14879 | |
| ANMVKLLLDRGAKID | 281 | Q12955 | |
| QGNMQLKELEKTLAL | 71 | Q9NU23 | |
| LIGVANQKMIELLAD | 656 | Q9H583 | |
| DILQLLKKNGGIVMV | 306 | Q9H4B8 | |
| NLEIVRKLKLLMGEN | 226 | Q02742 | |
| MGKIALQLKATLENI | 1 | Q9NWV4 | |
| QLMQQLKALLDPKGI | 496 | Q8N465 | |
| QLQLILFKVALMLGV | 161 | O94851 | |
| LDLNMDKQGVFTLLK | 591 | Q5VU65 | |
| RIKLMNEILNGIKVL | 501 | P33527 | |
| NKLVCMVKILQATGL | 866 | Q9NQT8 | |
| QLLQLKLGAQVMLVK | 471 | Q9H611 | |
| RANLLNMAKLSIKGL | 11 | Q8WXA3 | |
| TNILMLKGKNQAFLE | 86 | Q9UKA9 | |
| LTMLQLKKDLLIGIF | 496 | Q6ZMZ3 | |
| ELMAKLQKLQAAEGK | 306 | Q8IZP6 | |
| IKLIKGEAGQNLLEM | 331 | P0DJD1 | |
| GLKNIANTLMAKALQ | 791 | O94906 | |
| LEKDLNLMDIKIGLL | 821 | Q13576 | |
| NLMDIKIGLLVKNRI | 826 | Q13576 | |
| MLLNLSENPAVAKKL | 741 | Q96D09 | |
| LLLILEKQAAVMGQK | 11 | P04279 | |
| IAKNLILAGVKGLTM | 51 | Q9UBE0 | |
| LLLILEKQAAVMGQK | 11 | Q02383 | |
| EGQQLALNKEIMILK | 726 | Q5VT25 | |
| KQILMKDGLLDLNIA | 596 | P29973 | |
| ILLKMNKLDVNAEAA | 471 | Q8IV77 | |
| LFVLLTQLLKKMGAD | 936 | Q7Z460 | |
| VLLTQLLKKMGADLL | 736 | O75122 | |
| LLKKMGADLLGSVQA | 741 | O75122 | |
| IGLQEVNSMLNKRLK | 461 | Q15735 | |
| AIAQLLKKLLSQGMT | 766 | Q99570 | |
| DLVKGKQIAAALMLD | 521 | Q63HN8 | |
| GLLQLEMLQEKLKEL | 206 | O60296 | |
| LMKNLKPILLEVNAN | 521 | Q8NHH1 | |
| GIKQLLKDMLAANPQ | 501 | Q8TDR2 | |
| MLDARQLGLKLIANV | 2716 | O60673 | |
| MNGQLDLSGKLIIKA | 1 | Q92734 | |
| SKLMDQLEALKKQLG | 61 | Q9NP79 | |
| ALNDLGKKIQLVMKV | 701 | O95757 | |
| LALLVLGEAAKLNMA | 306 | C9JQI7 | |
| IGNIMEISNLLNKKA | 341 | Q5TCZ1 | |
| EKVLGKEVLLLMQAL | 91 | Q9BZA5 | |
| KDQALGKLEQSLRLM | 246 | Q13077 | |
| NQQSMLLADKVLKLL | 221 | O94826 | |
| AIILKVALNMARGLK | 141 | Q96KB5 | |
| VKNNQLIKDGEMVLL | 316 | Q9NQH7 | |
| LIGQKLKDLGIMKNI | 391 | Q9NQH7 | |
| GLLLLGMKENQELKT | 91 | Q9P0Z9 | |
| NLLKEIKDILKNMAG | 71 | Q9BXG8 | |
| KILKGLGKEANLLMQ | 136 | Q8N3L3 | |
| LGKEANLLMQNLNKL | 141 | Q8N3L3 | |
| LAIAQKLMELKLGKI | 356 | Q9BXT5 | |
| REAQKMAQLLVVLGK | 976 | Q9NYU1 | |
| HIKGLILKGDILMNQ | 736 | Q6ZXV5 | |
| ILKGDILMNQKKDIL | 741 | Q6ZXV5 | |
| KMNLVAINGLLLEAK | 2181 | O15050 | |
| MQEAKKLLGSLQLLF | 276 | Q9BZR9 | |
| NIVLLKNKAVLMPNG | 196 | Q6N021 | |
| TNLLMLKGKNQAFIE | 86 | P26599 | |
| LGMFNKILAQVEEKL | 1881 | Q6ZQQ6 | |
| LQALKGLKDLDLNMA | 956 | Q9P1Q0 | |
| IDNVILLMNGALQKK | 106 | Q8N8Y2 | |
| LLMNGALQKKSVKEI | 111 | Q8N8Y2 | |
| LKRLNVGMENKVVQL | 916 | Q9ULV0 | |
| MRLNQNTLLLGKKVV | 1 | Q9BTE0 |